Press "Enter" to skip to content

FDA Warns of a Rare Neurological Disorder Related to JandJ Vaccine

The US Food and Drug Administration (FDA)  is likely to make an announcement regarding a new warning for the COVID-19 vaccine by Johnson & Johnson Company. According to experts familiar with the event, the vaccine shot is linked to a serious and rare autoimmune disorder.

There are over 100 preliminary reports of the Guillain-Barre syndrome that were detected in individuals after injecting around 12.8 million doses of the vaccine, as stated by the CDC.

The disease Guillain-Barre is an uncommon neurological disorder in which the immune system of the person’s body attacks a part of their nervous system.

As per the trusted reports from the Institute of Neurological Disorders and Stroke, the disease is likely to affect at least one person in 100,000 every year, and most of the individuals are known to recover from the disease.

These cases were reported just two weeks after the vaccine shot was given to the people, and it occurs mostly in males, especially if they are 50 years or older than that.

There is not a sign of such autoimmune disorders among the patients who took Moderna’s or Pfizer’s Covid-19 vaccine.

The US FDA are likely to focus on the awareness regarding the safety of the vaccine as well as its benefits which outweigh the risks associated with it.

As per J&J officials, the incidents of autoimmune disease post-vaccination are very low. However, they also agree to improve the awareness amongst the citizens regarding symptoms and signs which can be treated effectively.

Be First to Comment

Leave a Reply

Your email address will not be published.